PATH Stock Slides As Traders Question AI Growth Story

UiPath Inc. stocks have been trading down by -3.44 percent amid bearish sentiment over automation demand and AI-competition risks.

Live Update At 16:46:36 EDT: On Wednesday, September 09, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.44%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PATH is trading like a broken growth story right now. The daily chart shows UiPath stock dropping from a recent close near $18.22 on 2026/09/03 to $13.57 by 2026/09/09. That is roughly a 25% slide in a few trading days, with most of the damage tied to the latest earnings release.

Under the hood, PATH is not a tiny, cash-burning story. UiPath posted about $410.3M in quarterly revenue and $36.1M in net income, translating to a diluted EPS of $0.07. Gross margin sits around a hefty 83%, and the balance sheet shows cash and short‑term investments of about $1.28B against long‑term debt of just $69.4M. Current ratio near 2.3 suggests PATH has plenty of liquidity.

Valuation is where traders need to stay sharp. A P/E around 25 and price‑to‑sales near 4.7 look reasonable for a software name, but only if growth and recurring revenue stay strong. UiPath’s asset turnover of 0.6 and returns on equity in the mid‑teens show improving efficiency, yet the recent plunge in PATH signals the market now doubts how durable that growth really is.

Why Traders Are Watching PATH After The Earnings Drop

PATH turned into a textbook momentum unwind after earnings. UiPath shares were hit for about 11% in early trading the morning after results, then the selloff deepened, with headlines pointing to a total decline of roughly 16%–17% as the session and following trading day played out. When a software name with a clean balance sheet gets punished that hard, traders take notice.

The Street’s message is clear. Bank of America bumped its PATH price target from $13 to $15, but kept an Underperform rating. That’s a subtle but important signal. Analysts see some improvement in margins at UiPath, yet they are not buying into a big AI‑driven acceleration in annual recurring revenue. For short‑term trading, that combination — modestly higher target but still bearish rating — often caps upside bounces and encourages fade setups into strength.

On the tape, PATH has slid from the high teens to the mid‑teens in a hurry. The intraday chart around $14–$13.50 shows tight, choppy action, with 5‑minute candles mostly pinned between $13.50 and $13.70 late in the day. That looks like price discovery after a gap‑down: weak hands shaken out, but no aggressive dip‑buying stampede yet.

UiPath adds another twist with insider activity. CEO Daniel Dines recently sold about 1.4M PATH shares, worth roughly $22.5M. He still controls about 26.5M Class A shares, so he remains heavily aligned with the company, but traders will still treat that sale as a yellow flag right after a bad reaction to earnings. In this kind of tape, every hint of management confidence — or lack of it — matters for PATH.

Conclusion

PATH now sits at the intersection of real fundamentals and damaged sentiment. On one side, UiPath is producing positive net income, strong gross margins, and solid free cash flow of about $29.3M last quarter. The company holds over $600M in cash, more than enough to fund product development and sales efforts. Financially, PATH is not in distress.

On the other side, the market has spoken. A 16%–17% drop linked directly to a quarterly report tells traders that expectations around UiPath’s AI narrative and ARR growth were too high. BofA’s decision to raise its price target to $15 while keeping UiPath at Underperform reinforces that skepticism. Traders now see PATH more as a show‑me story than a hot AI momentum play.

For active trading, that means clear rules and tighter risk. PATH can still offer sharp bounces and intraday range trades around support and resistance, but the dominant trend is down until the chart proves otherwise. As Tim Sykes always reminds his students, “Cut losses quickly and don’t believe the hype — let the price action confirm the story.” As millionaire penny stock trader and teacher Tim Sykes, says, “It’s not about how much money you make; it’s about how much money you keep.”. For PATH, the story now revolves around whether future quarters can rebuild trust and turn this ugly earnings dump into a longer‑term base, or if rallies will keep getting sold by traders who were burned on the last move. This content is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks